Idarucizumab Mechanism of Action

 
 
  • Home
  • Dabigatran and the Role of Reversal Agent
Idarucizumab Mechanism of Action

DOACs carry a risk of bleeding as with all antithrombotic therapies. A humanized monoclonal antibody was developed to reverse dabigatran anticoagulant effects in rare emergency situations. Let us see the mechanism of action of this antidote, idarucizumab.

1 month ago
PC-PH-102532 / August 2021
Click read more for Synopsis

DOACs carry a risk of bleeding as with all antithrombotic therapies. A humanized monoclonal antibody was developed to reverse dabigatran anticoagulant effects in rare emergency situations. Let us see the mechanism of action of this antidote, idarucizumab.

Related Videos for Dabigatran and the Role of Reversal Agent
Role of Idarucizumab in Neuro-Thrombolysis

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 1: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 2: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 3: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 4: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 6: Reversibility from a Neurologist’s Perspective, Prof Martin Grond

Prof. Dr. med. Martin Grond provides a neurologist’s perspective on the reversibility of NOAC therapies and in specific about reversing dabigatran anticoagulant effects using idarucizumab in life threatening emergency situations like ischemic stroke and ICH, based on a retrospective study and real-world experience.

1 month ago
Episode 1: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Use of direct oral anticoagulants has bridged the need for effective anticoagulation in patients with atrial fibrillation. Professor Anna Tomaszuk-Kazberuk throws light on the efficacy and safety of direct oral anticoagulants and use of idarucizumab to reverse their anticoagulant effect, when needed.

1 month ago
Episode 2: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Professor Anna Tomaszuk-Kazberuk discusses a case where cardiac surgeons initially refused to operate a patient on anticoagulant treatment and how idarucizumab has paved the way for proceeding with the contemplated procedure.

1 month ago
Episode 3: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

Professor Anna Tomaszuk-Kazberuk elaborates on how the use of idarucizumab changed the opinion of cardiac surgeons from withholding an emergency procedure for an imminent life-threatening condition to performing the same, while the patient was on dabigatran.

1 month ago
Episode 4: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

An elderly lady who had previous stroke and maintained on dabigatran had massive bleeding from her genital tract, as seen by her gynecologist. Professor Anna Tomaszuk-Kazberuk tells us how idarucizumab served as her rescue drug.

1 month ago
Episode 5: Reversibility from a Cardiologist’s Perspective, Prof Tomaszuk-Kazberuk

There are circumstances that may need for emergency reversal of anticoagulation in order to save lives of patients. Professor Anna Tomaszuk-Kazberuk deliberates on the use of idarucizumab by citing different clinical scenarios which were successfully managed with administration of idarucizumab based on her clinical experience.

1 month ago